The latest Mylan accounts are difficult to decipher - as they have lots of pending legal actions - and escrowed moneys are pooled.
I think from memory that Mylan are largely expecting to rely on (substantial) warranty amounts withheld in escrow from the purchase consideration to Strides (the old owners) - although any excess amounts are Mylan's responsibility (as the current owners of Agila). Perhaps it is more important to Strides?
Ann: Phosphagenics Market Update - Potential Return of Capital, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.28M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.4¢ | $26.59K | 6.419M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 7711400 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 20942354 | 23 |
View Market Depth
| Last trade - 15.22pm 16/07/2025 (20 minute delay) ? |
| AVE (ASX) Chart |